Robert Iliev
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- Renal and related cancers
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 3
- Extracellular vesicles in disease 1
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Co-authors
- Ondřej Slabý (14 shared papers)Marek Svoboda (12 shared papers)Alexandr Poprach (5 shared papers)Lenka Radová (7 shared papers)Rostislav Vyzula (6 shared papers)Jana Nekvindová (3 shared papers)Radek Lakomý (3 shared papers)Martina Rédová (3 shared papers)
In The Last Decade
Robert Iliev
18 papers receiving 770 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 489
- Molecular Biology 529
- Pulmonary and Respiratory Medicine 118
- Plant Science 63
- Oncology 26
Countries citing papers authored by Robert Iliev
This map shows the geographic impact of Robert Iliev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Iliev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Iliev more than expected).
Fields of papers citing papers by Robert Iliev
This network shows the impact of papers produced by Robert Iliev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Iliev. The network helps show where Robert Iliev may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Iliev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 227 | |
| 2 | 2012 | 90 | |
| 3 | 2016 | 80 | |
| 4 | 2015 | 74 | |
| 5 | 2012 | 70 | |
| 6 | 2016 | 63 | |
| 7 | 2018 | 52 | |
| 8 | 2016 | 48 | |
| 9 | 2016 | 40 | |
| 10 | 2016 | 24 | |
| 11 | THE ISOLATED PERFUSED KIDNEY MODELS - CERTAIN ASPECTS | 2011 | 5 |
| 12 | 2014 | 2 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 1 | |
| 15 | 2025 | 1 | |
| 16 | PARAMETERS OF LIPID METABOLISM AND THEIR RELATIONS WITH GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS | 2014 | 1 |
| 17 | MiR-215 is a tumor suppressor in colorectal cancer in vitro and in vivo | 2015 | 1 |
| 18 | 2014 | 1 |
About Robert Iliev
Robert Iliev is a scholar working on Molecular Biology, Cancer Research, Plant Science, Pulmonary and Respiratory Medicine and Surgery, having authored 18 papers that have together received 781 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), Chromosomal and Genetic Variations (4 papers), RNA modifications and cancer (3 papers), Extracellular vesicles in disease (1 paper), Organ Transplantation Techniques and Outcomes (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (489 citations), Molecular Biology (529 citations), Pulmonary and Respiratory Medicine (118 citations), Plant Science (63 citations) and Oncology (26 citations). Robert Iliev has collaborated with scholars based in Czechia, Austria and Germany. Frequent co-authors include Ondřej Slabý, Marek Svoboda, Alexandr Poprach, Lenka Radová, Rostislav Vyzula, Jana Nekvindová, Radek Lakomý, Martina Rédová, Jan Doležel and Michal Staník. Their work appears in journals such as Anticancer Research, Tumor Biology, Cancer Research, Cancer Genomics & Proteomics and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.